Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Billie Reid said his daughter Melissa has been struggling to cope as her bid to move to a Scottish prison was being processed.
The number of children in care has increased to its highest level for nearly 25 years, the Government's spending watchdog has said.
Abuse victims are being put through "torture" by the pace at which the Government's inquiry into abuse is progressing, an MP has said.